Serina Therapeutics, Inc. Operating Lease, Payments
Serina Therapeutics, Inc. (SER) reported Operating Lease, Payments of $56.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-05-14
- Serina Therapeutics, Inc. operating lease, payments for the quarter ending 2026-03-31 was $56.00K, a 0.00% change year-over-year.
- Serina Therapeutics, Inc. operating lease, payments for the quarter ending 2025-12-31 was $32.00K, a 33.33% decline year-over-year.
- Serina Therapeutics, Inc. operating lease, payments for the quarter ending 2025-09-30 was $50.00K, a 7.41% decline year-over-year.
- Serina Therapeutics, Inc. operating lease, payments for the quarter ending 2025-06-30 was $49.00K, a 14.04% decline year-over-year.
- Serina Therapeutics, Inc. operating lease, payments for fiscal 2025 was $187.00K, a 12.62% decline from fiscal 2024.
- Serina Therapeutics, Inc. operating lease, payments for fiscal 2024 was $214.00K, a 13.83% increase from fiscal 2023.
- Serina Therapeutics, Inc. operating lease, payments for fiscal 2023 was $188.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-03-31 | $56.00K 10-Q · filed 2026-05-14 | $88.00K derived: sum of 2 quarters · filed 2026-05-14 | $138.00K derived: sum of 3 quarters · filed 2026-05-14 | $187.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $82.00K derived: sum of 2 quarters · filed 2026-03-25 | $131.00K derived: sum of 3 quarters · filed 2026-03-25 | $187.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $99.00K derived: sum of 2 quarters · filed 2025-11-13 | $155.00K 10-Q · filed 2025-11-13 | $203.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $105.00K 10-Q · filed 2025-08-11 | $153.00K derived: sum of 3 quarters · filed 2026-05-14 | $207.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $56.00K 10-Q · filed 2026-05-14 | $104.00K derived: sum of 2 quarters · filed 2026-05-14 | $158.00K derived: sum of 3 quarters · filed 2026-05-14 | $215.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $102.00K derived: sum of 2 quarters · filed 2026-03-25 | $159.00K derived: sum of 3 quarters · filed 2026-03-25 | $214.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $111.00K derived: sum of 2 quarters · filed 2025-11-13 | $166.00K 10-Q · filed 2025-11-13 | $222.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $112.00K 10-Q · filed 2025-08-11 | $168.00K derived: sum of 3 quarters · filed 2025-08-11 | $215.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $55.00K 10-Q · filed 2025-05-08 | $111.00K derived: sum of 2 quarters · filed 2025-05-08 | $158.00K derived: sum of 3 quarters · filed 2025-05-08 | $199.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $103.00K derived: sum of 2 quarters · filed 2025-03-24 | $144.00K derived: sum of 3 quarters · filed 2025-03-24 | $188.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $88.00K derived: sum of 2 quarters · filed 2024-11-12 | $132.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $85.00K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $44.00K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |